tiprankstipranks
Trending News
More News >
Alnylam Pharmaceuticals (GB:0HD2)
LSE:0HD2

Alnylam Pharma (0HD2) Revenue

Compare
4 Followers

Alnylam Pharma Revenue

Alnylam Pharma had a revenue of 1.10B in the quarter ending Dec 31, 2025, with -12.17%. This bring the company's revenue in the last twelve months to 3.71B, Decreased 15.70%. In the fiscal year ending Dec 31, 2025, Alnylam Pharma had annual revenue of 3.71B with 65.19% growth.
Revenue (ttm)
3.71B
Revenue Growth
P/S Ratio
11.24
Revenue/Employee
$1,665,443
Employees
2,230
Market Cap
$41.75B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
3.71B1.47B+65.19%
Dec 31, 2024
2.25B419.95M+22.97%
Dec 31, 2023
1.83B790.87M+76.23%
Dec 31, 2022
1.04B193.13M+22.88%
Dec 31, 2021
844.29M351.43M+71.31%
Dec 31, 2020
492.85M273.10M+124.28%
Dec 31, 2019
219.75M144.84M+193.36%
Dec 31, 2018
74.91M-15.00M-16.69%
Dec 31, 2017
89.91M